AKR1C3-IN-12 (compound 2j), an inhibitor of aldo-keto reductase 1C3 (AKR1C3), exhibits potent activity with an IC50 of 27 nM. It has been shown to enhance the effectiveness of Gemcitabine and Cisplatin in treating bladder cancer [1].
Molecular Weight:
294.3
CAS Number:
[891075-67-5]
Formula:
C17H14N2O3
Target:
Reductase
T85610
* VAT and and shipping costs not included. Errors and price changes excepted